ArticleTheranostics2021

Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma.

Tao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.